You have 9 free searches left this month | for more free features.

T1DM

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 1 Diabetes, Type 2 Diabetes Trial in Tunbridge Wells (Four Week Self-Compassion Course)

Not yet recruiting
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Four Week Self-Compassion Course
  • Tunbridge Wells, United Kingdom
    Salomons Institute for Applied Psychology, Canterbury Christ Chu
Mar 1, 2023

Endothelial Dysfunction, Diabetes, Type 1, Biomarkers Trial in Celje (Semaglutide Pen Injector [Ozempic], Empagliflozin 10 MG)

Completed
  • Endothelial Dysfunction
  • +9 more
  • Semaglutide Pen Injector [Ozempic]
  • Empagliflozin 10 MG
  • Celje, Slovenia
    General Hospital Celje
May 10, 2023

Brain Health and Development With T1DM

Active, not recruiting
  • T1DM
  • Brain Development
    • Saint Louis, Missouri
      Washington University School of Medicine
    Feb 2, 2022

    The True Vie I3 Continuous Glucose Monitoring System in

    Not yet recruiting
    • T1DM - Type 1 Diabetes Mellitus
    • 13 CGM (continuous glucose monitor)
    • (no location specified)
    Jun 9, 2023

    Diabetes, Diabetes, Type 1, Lipohypertrophy Trial in Roma (Medtronic Extended Infusion Set)

    Completed
    • Diabetes
    • +2 more
    • Medtronic Extended Infusion Set
    • Roma, Italy
      Azienda Ospedaliera San Camillo Forlanini
    Oct 6, 2023

    Male LADA, T1DM and T2DM Patients

    Completed
    • Diabetes
    • No interventions
    • Shanghai, Shanghai, China
      Department of Endocrinology, Shanghai Tenth People's Hospital
    Sep 8, 2022

    Type 1 Diabetes Trial in Mainz, Neuss (M1 Pram P037, Insulin lispro)

    Completed
    • Type 1 Diabetes Mellitus
    • M1 Pram P037
    • Insulin lispro
    • Mainz, Germany
    • +1 more
    Jun 23, 2022

    Diabetes, Type 1, Type 1 Diabetes Trial in Escondido (coil-reinforced soft polymer indwelling cannula, soft Teflon indwelling

    Completed
    • Diabetes Mellitus, Type 1
    • Type 1 Diabetes
    • coil-reinforced soft polymer indwelling cannula
    • soft Teflon indwelling catheter
    • Escondido, California
      AMCR Institute
    Aug 9, 2022

    Type1 Diabetes Trial in Hong Kong (Intervention arm - A new smartphone application for pediatric type 1 DM, Standard diabetic

    Recruiting
    • Type1 Diabetes Mellitus
    • Intervention arm - A new smartphone application for pediatric type 1 DM
    • Standard diabetic eduction
    • Hong Kong, Hong Kong
      Hong Kong Children's Hospital
    Jun 12, 2022

    Type 1 Diabetes Trial in Abu Dhabi (ECP regular-intensity arm, ECP accelerated-intensity arm, T1DM standard of care)

    Recruiting
    • Type 1 Diabetes
    • ECP regular-intensity arm
    • +2 more
    • Abu Dhabi, United Arab Emirates
      Abu Dhabi Stem Cells Center
    Oct 28, 2022

    Diabetes, Type 1 Trial in Chula Vista (AT247, NovoLog, Fiasp)

    Active, not recruiting
    • Diabetes Mellitus, Type 1
    • Chula Vista, California
      ProSciento, Inc
    Aug 12, 2022

    Type1 Diabetes Trial in New Haven (CL/AP system, usual diabetic care)

    Terminated
    • Type1 Diabetes Mellitus
    • CL/AP system
    • usual diabetic care
    • New Haven, Connecticut
      Yale New Haven Hospital
    Nov 16, 2022

    Trastuzumab Emtansine as Therapy in Chinese HER2 Positive

    Not yet recruiting
    • Breast Cancer
    • Trastuzumab emtansine
    • (no location specified)
    Jul 13, 2023

    To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children Trial in

    Completed
    • To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children
    • Glargine and regular insulin versus NPH and regular insulin
    • Lahore, Punjab, Pakistan
      Pediatric endocrine and diabetes section, Pediatric department,
    Jan 29, 2023

    Diabetes, Type 1 Trial in Cleveland (Virtual Educational Program)

    Completed
    • Diabetes Mellitus, Type 1
    • Virtual Educational Program
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center
    Oct 26, 2022

    Type 1 Diabetes Trial in New Haven (canagliflozin, basal interruption without canagliflozin)

    Completed
    • Type 1 Diabetes
    • New Haven, Connecticut
      Yale University School of Medicine
    Sep 17, 2021

    Advanced Breast Cancer, Objective Response Rate, Trastuzumab Emtansine Trial in Nanjing (Trastuzumab Emtansine (T-DM1))

    Recruiting
    • Advanced Breast Cancer
    • +2 more
    • Trastuzumab Emtansine (T-DM1)
    • Nanjing, Jiangsu, China
      JiangSu Province Hospital/ The First Affiliated Hospital of Nanj
    Nov 5, 2023

    Diabetes, Type 1, Immunologic Deficiency Syndromes Trial in Shanghai (Sequential transplantation)

    Recruiting
    • Diabetes Mellitus, Type 1
    • Immunologic Deficiency Syndromes
    • Sequential transplantation
    • Shanghai, Shanghai, China
      Children's Hospital of Fudan University
    Aug 4, 2022

    Healthy Subjects, Obesity, T2DM (Type 2 Diabetes) Trial in Changchun (HEC88473 injection, Placebo)

    Completed
    • Healthy Subjects
    • +2 more
    • HEC88473 injection
    • Placebo
    • Changchun, Jilin, China
      The First Hospital of Jilin University
    Jul 14, 2023

    Breast Cancer Trial (Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F

    Not yet recruiting
    • Breast Cancer
    • Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F Conjugates for Injection (FS-1502)
    • Control drug: Trastuzumab emtansine (Kadcyla, T-DM1)
    • (no location specified)
    Feb 22, 2023

    Salivary Gland Cancer, HER2 Gene Mutation Trial in Boston (Ado-trastuzumab (T) emtansine (T-DM1), Standard of Care Radiotherapy,

    Recruiting
    • Salivary Gland Cancer
    • HER2 Gene Mutation
    • Ado-trastuzumab (T) emtansine (T-DM1)
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Jan 2, 2023

    Metastatic Solid Tumor, Brain Metastases Trial in Houston (Trastuzumab emtansine, Tucatinib)

    Not yet recruiting
    • Metastatic Solid Tumor
    • Brain Metastases
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 30, 2022

    Type 1 Diabetes Trial (MHS552, Placebo)

    Not yet recruiting
    • Type 1 Diabetes Mellitus
    • (no location specified)
    May 28, 2022

    Type 1 Diabetes Trial in Karachi (Blood draw for insulin auto-anti body tests*)

    Completed
    • Type 1 Diabetes
    • Blood draw for insulin auto-anti body tests*
    • Karachi, Sind, Pakistan
      National Institute of Child Health
    Apr 21, 2022

    Ado-trastuzumab Emtansine-Induced Peripheral Neuropathy in

    Recruiting
    • Breast Neoplasm
      • Rochester, Minnesota
        Mayo Clinic Minnesota
      Jun 12, 2023